Fig. 2.
![Fig. 2. Annual hazard rates of end-stage liver disease (ESLD) among hepatitis C virus (HCV)– and HIV-seropositive participants with complete data in the MHCS. / By age group ([A] n = 1192), hepatitis B virus (HBV) status ([B] n = 1180), and CD4+ lymphocyte count ([C] n = 1049).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/100/5/10.1182_blood.v100.5.1584.h81702001584_1584_1589/3/h81723060002.jpeg?Expires=1723926449&Signature=P~t5fukt8dcSA-UwTfpGWuDygSEY1z9ZEONQfjaEa8~qqZF9yynlxtCQMmQsGuZM7sbnIjpXQs6Tc5EDBdhGz5W~7cHf~6EPcN2sMB02HpAmRrp6gDOyVLZxpq5K0q1Q9MQUjIsj~K86O8a~jKdOQQpcQil1SMwPSWAQ0YRQeipKpl7dKd8PJNKxGzld0lfIadY4Kv1tSCwBEt-5p28nD5tMtPXeMAYIL2qSYLlM~3Ar0jyP7cfUYmlHINQZ8hRKnVewSXkjPy7L4duU6fuK9j6l2fGAcYNlPseelq8PhCDm3vaPHh~dagCisiUk9in-bFdRJz5Aa3QPJL6ItCaSKg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Annual hazard rates of end-stage liver disease (ESLD) among hepatitis C virus (HCV)– and HIV-seropositive participants with complete data in the MHCS.
By age group ([A] n = 1192), hepatitis B virus (HBV) status ([B] n = 1180), and CD4+ lymphocyte count ([C] n = 1049).
